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Pneumonia is one of the leading causes of death and mortality worldwide. The inflam-
matory responses that follow respiratory infections are protective leading to pathogen 
clearance but can also be deleterious if unregulated. The microbiota is known to be 
an important protective barrier against infections, mediating both direct inhibitory effects 
against the potential pathogen and also regulating the immune responses contributing to 
a proper clearance of the pathogen and return to homeostasis. GPR43 is one receptor 
for acetate, a microbiota metabolite shown to induce and to regulate important immune 
functions. Here, we addressed the role of GPR43 signaling during pulmonary bacterial 
infections. We have shown for the first time that the absence of GPR43 leads to increased 
susceptibility to Klebsiella pneumoniae infection, which was associated to both uncon-
trolled proliferation of bacteria and to increased inflammatory response. Mechanistically, 
we showed that GPR43 expression especially in neutrophils and alveolar macrophages 
is important for bacterial phagocytosis and killing. In addition, treatment with the GPR43 
ligand, acetate, is protective during bacterial lung infection. This was associated to 
reduction in the number of bacteria in the airways and to the control of the inflammatory 
responses. Altogether, GPR43 plays an important role in the “gut–lung axis” as a sensor 
of the host gut microbiota activity through acetate binding promoting a proper immune 
response in the lungs.
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inTrODUcTiOn
Pneumonia remains a leading cause of death and hospitalization worldwide, especially among chil-
dren and the elderly. It is estimated that more than 150 million cases occur annually among children 
under 5 years old, leading to approximately 2 million deaths each year (1). Pneumonia is a lower res-
piratory tract disease characterized by an intense inflammatory response, which results in increased 
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lung edema, loss of respiratory area, and can lead to respiratory 
impairment and death (2–4). It can be caused by several patho-
gens, such as virus, fungi, and bacteria. Among bacterial causes of 
pneumonia, Streptococcus pneumoniae and Klebsiella pneumoniae 
(Kp) are the main causes of community-acquired pneumonia or 
nosocomial pneumonia, respectively (5, 6).
During respiratory tract infections, the inflammatory response 
is very important to control pathogen replication and dissemina-
tion; however, the inflammation itself could be harmful for the 
host as a collateral damage (7). The overproduction of cytokines 
and chemokines and the overactivation of leukocytes, especially 
neutrophils, can lead to an intense lung injury. Therefore, the 
lungs have several mechanisms to assure an effective clearance 
of potential pathogens and to restrain the overwhelming inflam-
mation that could lead to a worse outcome (8). In this regard, 
a community of indigenous microorganisms composing the 
host microbiota is important to guarantee the balance between 
proper immune response and minimum tissue damage (9, 10). 
The host microbiota can exert its actions through both direct and 
indirect effects, such as by the production of short-chain fatty 
acids (SCFA) (11). Those microbial metabolites are not only 
nutrients, being used as an energy source for colonocytes, but 
also act as signaling molecules. Therefore, SCFA were shown to 
be important regulating crucial host cellular processes such as 
adipogenesis, intestinal function, and also inflammation (12). 
Indeed, SCFA were shown to increase some important functions 
of leukocytes, such as production of reactive oxygen species (13), 
but also to downregulate the production of pro-inflammatory 
cytokines and the magnitude of neutrophilic inflammation in 
several disease models (14).
The majority of SCFA produced by microbiota fermentation 
are acetate, propionate, and butyrate. Those molecules can act by 
epigenetic changes due to inhibition of histone deacetylase and 
through binding and activation of orphan G-protein-coupled 
receptors, such as GPR41, GPR43, and GPR109 (15). GPR43 
binds and gets activated specially by acetate, and it is considered 
an important dietary nutritional sensor (16, 17). Because gut 
microbiota is the main source of SCFA and is very sensitive to 
nutritional alterations (18), changes in microbiota reflect a 
decreased SCFA production and GPR43 activation. This receptor 
is highly expressed in inflammatory cells, such as neutrophils and 
macrophages (MF) (11), therefore sensing the nutritional status of 
the host and regulating important functional aspects in immune 
responses (19). GPR43 was shown to be important for the pro-
duction of intestinal IgA (20) and also for the development of 
inflammatory response during different diseases, such as asthma 
(19), gout (13), and colitis (21). In this regard, the presence of gut 
microbiota and sensing of their metabolites through GPR43 leads 
to a modulation of local and systemic inflammatory responses 
important to the mucosal tissues.
Despite its involvement in several inflammatory diseases, the 
role of GPR43 during lung infections has never been addressed. 
Therefore, we showed here, for the first time, the importance of 
GPR43 during respiratory infections being this receptor impor-
tant for both clearance of bacteria and most importantly for the 
regulation of immune responses, which could lead to lung damage 
during infections.
MaTerials anD MeThODs
Mice
GPR43/FFAR2 gene-deficient (Gpr43−/−) mice were produced 
as previously described (11) backcrossed onto the C57BL/6 
background for 10 generations, and maintained in the animal 
facilities at Universidade Federal de Minas Gerais (UFMG; Belo 
Horizonte, Brazil). Wild-type male C57BL/6 mice (8–12 weeks) 
were obtained from the centre of animal care (CEBIO) from 
UFMG. Mice were maintained in pathogen-free and co-housing 
conditions with free access to filtered water and food. This study 
was carried out in accordance with the recommendations of the 
local animal ethics committee at Universidade Federal de Minas 
Gerais (CETEA/UFMG 219/2014).
Pulmonary infection
Klebsiella pneumoniae (ATCC 27736) lung infection was made 
as previously described (22). Briefly, animals were anesthetized 
i.p. with 0.2  mL of a solution containing xylazine (02  mg/mL), 
ketamine (50  mg/mL), and saline in a proposition of 1:0.5:3. 
The trachea was exposed and 25 µL of a suspension containing 
1 × 106 CFU of Kp or saline was administered with a 26-gauge 
needle. After the infection, the animals were euthanized at differ-
ent time points.
Streptococcus pneumoniae (ATCC 6303 serotype 3) (Sp) infec-
tion was made as previously described (7). Briefly, mice were 
instilled intranasally with 105 or 106 CFU of Sp in 40 µL and were 
euthanized at 48 h post infection. The data were not shown, and it 
is only mentioned in the Section “Result.”
acetate Treatment
Mice were given sodium acetate (Sigma-Aldrich, St. Louis MO, 
USA) for 5  days before the infection until they were killed. 
Acetate was added in the sterile drinking water of mice ad libitum 
at 150 mM. The acetate dose was chosen according previous data 
(11, 13), and pH was adjusted as needed. The water solution 
was changed every day to avoid contamination and significant 
changes.
BalF and Tissue extraction
Mice were euthanized with a lethal solution of ketamine/xylazine 
(180 and 12  mg/kg, respectively), and bronchoalveolar lavage 
(BAL) was performed by inserting and collecting three times 1 mL 
aliquots of phosphate-buffered saline (PBS), through a 1.7-mm 
catheter in a 1-mL syringe to quantify leukocytes recruited to 
the airways and bacteria counts. Total counts were performed by 
Neubauer chamber count. Differential counts were obtained from 
cytospin preparations. Lungs were collected for quantification 
of myeloperoxidase to assess neutrophil infiltration, cytokines 
determination, and histological examination of lung injury.
cytokine Determination
Tissues were collected and homogenized in PBS containing anti-
proteases (22). Samples were centrifuged, and the supernatant was 
used for cytokine concentrations, in accordance with the manufac-
turer’s instructions (R&D Systems, Minneapolis, MN, USA).
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histological analysis
For histopathological analysis, lungs were removed and fixed for 
24 h in 10% neutral buffered formalin (Sigma-Aldrich, St. Louis 
MO, USA). Samples were washed with PBS and dehydrated. 
After embedding in paraffin, 3-mm sections were obtained and 
stained with hematoxylin and eosin to allow assessment of inflam-
mation in the lung. All lung sections, H&E-stained and at 100× 
magnification (11 mm2/field), were evaluated in a blinded manner. 
Two parameters were measured: severity of inflammation (0–3: 
none, slight, moderate, severe) and presence of edema (0–2: none, 
one-third damaged, and two-thirds damaged). The score of each 
parameter was multiplied by a factor reflecting the percentage 
of tissue involvement (1, 0–25%; 2, 26–50%; 3, 51–75%; and 4, 
76–100%) and added to a sum. The maximum possible score is 20.
Phagocytosis assay
The phagocytosis assay was performed as previously described 
(23). Briefly, MF and neutrophils isolated from the bone marrow 
by gradient percoll separation were incubated in the presence of 
acetate (1  mM) and opsonized-pHRodo-marked Kp (MOI1:1). 
Cells [0.5 × 106 for neutrophils and 0.5 × 105 alveolar macrophage 
(AM)] were incubated in RPMI 1640 medium without antibiot-
ics supplemented with 10% heat-inactivated FBS for 60 (AM) or 
120 min (neutrophils). Cells were then washed, resuspended in 
100  µL PBS, and incubated with anti-F4/80 (APC anti-mouse 
F4/80 Clone BM8, BioLegend, San Diego, CA, USA) and −CD45 
(Pe-Cy7 anti-mouse CD45, BioLegend) or anti-Ly-6G (PE anti-
mouse Ly-6G Clone 1A8, BioLegend). Trypan blue at a final 
concentration of 0.5% was added to quench the fluorescence of 
non-internalized bacteria. Negative controls consisting of cells 
incubated without Kp were used to set the fluorescence. Samples 
(10,000 events) were analyzed by flow cytometry (Gallios, 
Beckman Coulter, Brea, CA, USA). Both the percentage of cells 
that internalized bacteria and the mean fluorescence of bacteria 
within the cells were analyzed.
Killing assay of aM
Alveolar macrophage (0.5 × 105) were incubated in the presence 
of acetate (1 mM) and opsonized Kp. Samples were incubated in 
RPMI 1640 medium without antibiotics supplemented with 10% 
heat-inactivated FBS for 30 or 120  min. Cells were centrifuged 
(1,500  rpm, 10  min, 4°C), and the supernatant was collected, 
serially diluted in sterile PBS (1/10, 1/1,000, and 1/100,000) 
and plated in triplicate at MacConkey agar. A 10-µL volume of 
undiluted bacteria and bacterial incubated in the absence of cells 
(total bacteria) were also plated as positive control. The plates 
were incubated in incubator at 37°C for 24 h. Colonies were then 
counted and the total number of CFU was obtained considering 
the dilution of the sample. The number of CFU was normalized 
considering the viable bacteria counted in the control condition 
(WT without treatment).
Measurement of cytokines Produced by 
neutrophils and BMDM
Bone marrow isolated neutrophils (0.5  ×  106) and BMDM 
(1.5  ×  105) were incubated in medium RPMI 1640 without 
antibiotics and supplemented with 10% FBS in the presence or 
absence of Kp (MOI: 1:1) and acetate (1 mM) for 120 min. The 
supernatant of the cultures was collected and then assayed for 
cytokines (TNF-α, IL-1β, and IL-10) as described above.
neutrophil chemotaxis assay
Residents peritoneal MF were harvested from wild-type and 
Gpr43−/− mice pretreated for 5  days or not with oral acetate 
(150  mM). Macrophages (1  ×  106 cells/well) were plated and 
stimulated with lipopolysaccharides (LPS) (1 µg/mL) for 24 h, and 
the supernatant was collected. Thioglycollate elicited neutrophils 
from wild-type and Gpr43−/− were collected 18 h after intraperi-
toneal administration. Neutrophils were plated (1 × 105 cells/well) 
on top of the filter membrane in a transwell insert and incubated 
for 10 min at 37°C and 5% CO2 to allow the cells to settle down. 
Macrophage supernatant was used as a chemoattractant into 
the bottom of the lower chamber in a 24-well plate. Cells were 
incubated for 30  min. The quantification of migrated cells was 
performed by count the migrated cells dropped into the media in 
the lower chamber. The number of migrated cells was counted by 
using flow cytometer and the confirmation by cytospin.
aM Transference In Vivo
Wild-type mice were pretreated for 5  days with oral acetate 
(150 mM). Mice were euthanized with a lethal solution of keta-
mine/xylazine and BAL was performed by inserting and collecting 
three times 1 mL aliquots of PBS, through a 1.7-mm catheter in a 
1-mL syringe. The isolation of AMs were performed as previously 
described (24). Briefly, AM were harvested from BAL and isolated 
by adherent cells to plastic for 1 h at 37 C in 5% CO2. The purity 
was confirmed by morphological analysis by cyotspin (92% of 
AM). For adoptive in vivo transfer AM were recovered by cold 
PBS and 2 × 105 cells were instilled intranasally in wild-type and 
Gpr43−/− mice 1 h before the Kp infection. 24 h after infection, 
mice were euthanized, and the BAL was performed. CFU and 
number of neutrophils were analyzed.
statistical analyses
All results are presented as the means ±  SEM. The analyses of 
the difference between two groups were performed by Student’s 
t-test. Normalized data of three or more groups were analyzed 
by one-way and two-way ANOVA, and differences between 
groups were assessed using the Newman–Keuls and Sidak’s 
posttest respectively. Results were considered significant when 
P ≤ 0.05. Calculations were performed using Prism 5.0 software 
for Windows (GraphPad Software, La Jolla, CA, USA).
resUlTs
gpr43−/− Mice are More susceptible  
to Kp lung infection
Gpr43 is a receptor that binds to SCFA, particularly acetate, 
and is highly expressed on neutrophils and MF (11). To better 
understand the role of Gpr43 and its effects during infection, 
wild-type and Gpr43−/− mice were infected with Gram-negative 
bacteria, Kp, by intratracheal challenge (1  ×  106  CFU). Mice 
FigUre 1 | Gpr43−/− mice are more susceptible to Gram-negative [Klebsiella pneumoniae (Kp)] lung infection. (a) Survival rate of mice were observed during 7 days 
following intratracheal Kp (1 × 106 CFU). (B) Weight loss infection post-Kp infection. (c) Bacterial burden in the airways was assessed in bronchoalveolar fluid 
[bronchoalveolar lavage (BAL)] 48 h post-Kp infection. (D) Representative photographs of H&E-stained sections of lung from wild-type mice control [WT phosphate-
buffered saline (PBS)], wild-type mice Kp infected (WT INF), Gpr43−/− mice control (Gpr43−/− PBS) and Gpr43−/− mice infected (Gpr43−/− INF). Scale bar—400 mm. 
Results are expressed as mean ± SEM of 8–10 mice per group. *Statistical difference (P < 0.05) when comparing to WT and Gpr43−/− mice. ***Statistical difference 
(P < 0.001) when comparing to WT and Gpr43−/− mice. Results representative of three independent experiments and the statistical (ANOVA—Posttest Newman–
Keuls) was used.
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weight and lethality were monitored for 7  days. Interestingly, 
Gpr43−/− mice exhibited an increased susceptibility to infection, 
as observed by the higher mortality (Figure 1A) and by weight 
loss (Figure 1B) when compared to wild-type infected animals. 
These factors were associated to an increased burden of bacteria 
in the airways of Gpr43−/− mice (Figure 1C). Histological analyses 
and score (WT PBS: 0; WT INF: 15.6 ±  1.15; GPR43−/− PBS:0; 
GPR43−/− INF:13.3 ± 2.3) showed a higher level of lung injury, 
which was observed by increased pulmonary edema and inflam-
matory cell infiltration in lung parenchyma and airways after 48 h 
of Kp infection in both Gpr43−/− and wild-type mice (Figure 1D). 
Toward these results, we investigated whether the protective role 
of GPR43 was also evident during a Gram-positive bacterial infec-
tion. For that, Gpr43−/− and wild-type mice were infected with 
Sp. After 48 h of pneumococcal infection, we observed an equally 
high susceptibility of Gpr43−/− mice to infection (sixth day: 40% 
mortality in WT and 100% mortality in Gpr43−/− mice—data not 
shown). All together, these data suggest that GPR43 is important 
to control bacterial infection in the lungs.
Timely resolution of Pulmonary 
inflammation in gpr43−/− Mice Was 
impaired When compared to WT Mice 
after Kp infection
Next, aiming to evaluate the inflammatory response that follows 
Kp infection, Gpr43−/− and wild-type mice were injected with 
1 × 106 CFU intratracheally, and inflammation was evaluated at 
different time point. As previously shown (22), Kp infection leads 
to an increased infiltration of leukocytes into the airways and 
our results showed that there was marked airway inflammatory 
cells infiltration during the outcome of the infection (Figure 2). 
FigUre 2 | The onset of inflammatory cells in the lung of Gpr43−/− mice 48 h after Klebsiella pneumoniae infection. (a) Number of total cells infiltration, (B) 
neutrophils, and (c) mononuclear cells in airway spaces recovered using bronchoalveolar lavage (BAL) were counted at different time points (0–48 h) after 
intratracheal inoculation of 1 × 106 CFU of Kp. (D) Myeloperoxidase activity in homogenized lungs harvested from wild-type and Gpr43−/− mice. (e) IL-1β levels and 
(F) TNF-α levels were measured by ELISA in BAL supernatant harvested from wild-type and Gpr43−/− mice 48 h after Kp infection. Results are presented as 
mean ± SEM (n = 6). *Statistical difference (P < 0.05) when comparing to WT and Gpr43−/− mice. ***Statistical difference (P < 0.001) when comparing to WT and 
Gpr43−/− mice. Results representative of three independent experiments and the statistical (ANOVA—Posttest Newman–Keuls) was used.
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There is no difference between Gpr43−/− and wild-type mice at 
24 h regarding total cells infiltration (Figure 2A) and neutrophils 
(Figure  2B). Although wild-type mice seems to exhibited less 
mononuclear cells compared to GPR43−/− mice at 24 h as observed 
in (Figure 2C), also, there was no significant difference between 
them. At 48  h post-Kp infection, Gpr43−/− exhibited more total 
cells infiltration (Figure 2A) and neutrophils (Figure 2B) and less 
mononuclear cells (Figure 2C) when compared to wild-type mice. 
However, there were no significant differences in the neutrophils 
that migrated into the lung tissue measured by the activity of 
myeloperoxidase (Figure 2D) at 48 h post Kp infection. In accord-
ance with marked airway inflammation, the levels of the pro-
inflammatory cytokines IL-1β and TNF-α were increased in the 
BAL when compared to wild-type infected mice (Figures 2E,F). 
Taken together, these results indicate that inflammation persists 
longer in Gpr43−/− airspaces, thus Gpr43 plays an important role 
in the control of inflammation induced by Kp infection.
Oral Treatment with the gpr43 Metabolic 
ligand, acetate, ameliorates Kp-induced 
Pulmonary inflammation
Because acetate is the mostly abundant microbial metabolite 
produced which is also able to reach systemic levels and to bind 
to Gpr43, we pretreated mice with acetate in drinking water 
(150 mM) for 5 days and then infected with Kp. We observed that 
acetate treatment was able to reduce the mortality and bacterial 
counts (Figures  3A,B). Mononuclear cells were increased in 
the airway space in acetate-treated mice 48 h post-Kp infection 
(Figure 3F). Neutrophil infiltration is a sign of inflammation, and 
neutrophil clearance is the most important marker of recovery 
from inflammation. Accordingly to this, we observed a reduc-
tion in myeloperoxidase activity in the lungs and neutrophils in 
the airway space (Figures 3C–E) with no alteration in the total 
number of cells after acetate treatment. Acetate was able to protect 
lungs from pathological injury observed by reduced pulmonary 
inflammatory cell infiltration in lung parenchyma (Figure 3G). 
Furthermore, we also treated mice with acetate (150 mM—oral 
gavage) 24 h after infection and it was also able to reduce neu-
trophils in the airway space (Figure  3H). In accordance with 
previous results, oral treatment with acetate reduces TNF-α and 
IL-1β levels in lungs 48  h after Kp infection (Table  1). These 
data corroborate with the Gpr43−/− result, suggesting the role of 
acetate/Gpr43 activation in the control of inflammation induced 
by Kp infection.
Macrophages from gpr43−/− Mice had 
impaired Phagocytosis, and In Vivo 
Transference restores the Protective 
Phenotype
To gain further insight into the possible mechanism by which 
Gpr43 are involved in the protection of Kp infection, we analyzed 
TaBle 1 | Cytokine levels in the lung of mice.
Phosphate-
buffered saline
WT WT + acetate
TNF-α (pg/ml) 1,948.71 ± 123.6 3,787.36 ± 187.0 2,078.87 ± 589.1*
IL-1-β (pg/ml) 663.82 ± 27.72 3,829.19 ± 396.19 2,261.96 ± 833.55*
*Statistical significance. P < 0.05.
FigUre 3 | Oral Treatment with the Gpr43 metabolic ligand, acetate in the lung 48 h after Klebsiella pneumoniae (Kp) infection. (a) Survival rate of mice pretreated 
for 5 days with acetate were observed during 7 days following intratracheal Kp (1 × 106 CFU). (B) Bacterial burden in the airways was assessed in lung 48 h 
post-Kp infection. (c) Myeloperoxidase activity in homogenized lungs harvested from wild-type and wild-type pretreated for 5 days with acetate. (D) Number of total 
infiltrated cells, (e) neutrophils, and (F) mononuclear cells in airway spaces recovered using bronchoalveolar lavage were counted at 48 h post-Kp infection. (g) 
Representative photographs of H&E-stained sections of lung from wild-type mice control [phosphate-buffered saline (PBS)], wild-type mice Kp infected, and 
wild-type pretreated 5 days with acetate Kp infected (acetate). Scale bar—400 mm. (h) Number of neutrophils from posttreatment mice with acetate (150 mM) by 
gavage 24 h after Kp infection. Results are expressed as mean ± SEM of 8–10 mice per group. *Statistical difference (P < 0.05) when comparing to WT and 
WT + acetate. ***Statistical difference (P < 0.001) when comparing to WT and WT + acetate. Results representative of three independent experiments and the 
statistical (ANOVA—Posttest Newman–Keuls) was used.
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the capacity of AMs to phagocytose bacteria. Resident AMs are 
the first line of lung defense against respiratory pathogens without 
evoking a measurable systemic inflammatory response. Because 
MF have been shown to be important during Klebsiella-induced 
pneumonia (22), we decided to investigate the contribution of 
Gpr43−/− MF into their susceptible phenotype. We observed 
that MF from Gpr43−/− mice had impaired phagocytosis when 
compared to the wild type (Figure 4A). Therefore, this might be 
a possible mechanism of increased bacterial burden in Gpr43−/− 
mice. To prove this hypothesis, we transferred in vivo AM from 
wild-type mice to Gpr43−/− mice, intranasally, 1  h before the 
Kp infection. The AMs from wild-type mice restored protective 
phenotype on Gpr43−/−, showing a reduction of bacterial burden 
in the airways. Interestingly, AM recovered from acetate-treated 
WT mice reduced bacteria numbers on WT mice. Our results 
suggest the importance of Gpr43 in the clearance of bacteria 
(Figure 4B).
neutrophils from gpr43−/− Mice had 
impaired chemotaxis, Phagocytosis, and 
cytokine Production
It was observed that Gpr43−/− mice present a marked lung inflam-
matory neutrophil infiltration; however, the role of neutrophils 
FigUre 4 | Macrophages from Gpr43−/− had impairment in phagocytosis and alveolar macrophages (AM) transference in vivo restore protective phenotype. (a) 
Macrophages from wild-type and Gpr43−/− were incubated with opsonized-pHRodo-marked Kp (MOI 1:1) for 60 min. Samples were analyzed by flow cytometer, 
and the mean fluorescence of bacteria within the cells were analyzed. (B) Bacterial burden in the airways was assessed in bronchoalveolar fluid 24 h post-Kp 
infection. Results are presented as mean ± SEM (n=6). *Statistical difference (P < 0.05) when comparing to WT control (ANOVA—Posttest Newman–Keuls). 
#Statistical difference (P < 0.05) when compared with WT infected (ANOVA—Posttest Newman–Keuls). Results representative of three independent experiments.
FigUre 5 | Neutrophils from Gpr43−/− mice present less chemotaxis. 
Peritoneal macrophage (MF) harvest from wild-type mice treated or not with 
150 mM of acetate was stimulated with lipopolysaccharides (LPS) for 24 h. 
The supernatant MF culture was used as a chemoattractant to bone marrow 
neutrophils elicited from wild-type and Gpr43−/− mice. Results are presented 
as mean ± SEM (n=6). *Statistical difference (P < 0.05) when compared with 
WT (ANOVA—Posttest Newman–Keuls). #Statistical difference (P < 0.05) 
when compared with WT + Acetate (ANOVA—Posttest Newman–Keuls). 
Results representative of three independent experiments.
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during Kp infection was not yet fully investigated. In order to 
investigate the role of Gpr43−/− in neutrophils, resident MF 
from wild-type and Gpr43−/− pretreated or not with oral acetate 
were stimulated with LPS for 24  h. The supernatant was used 
as a chemoattractant to the elicited bone marrow neutrophils. 
Neutrophils from Gpr43−/− mice showed reduced migration when 
compared to the wild-type mice and the treatment with acetate 
was able to increase neutrophils migration from WT mice, which 
was not observed in GPR43−/− mice (Figure 5). This result show 
that GPR43 receptor expressed on neutrophil’s surface played 
an important role in neutrophil activity state and subsequent 
migration. In order to better understand the role of GPR43 in 
neutrophils, we analyzed their capacity to phagocytose bacteria. 
As observed in MF, neutrophils from Gpr43−/− mice also show 
reduced capacity to phagocytose bacteria when compared to the 
wild type (Figure  6A). These results are accompanied with no 
significant difference in cytokine levels between wild-type and 
Gpr43−/− mice (Figures 6B,C).
DiscUssiOn
The importance of gut microbiota mediating several features 
of gut immune responses has been appreciated since the past 
decade. More recently, the relationship between gut microbiota 
and the lungs (the called “gut–lung axis”) has also been addressed 
(25–27). Both lungs and gut have an immense surface area and 
are exposed to several allergens and pathogens on a daily basis. 
Therefore, both organs have important barriers against harmful 
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particles or pathogens. One of those barriers is the presence of 
indigenous microorganisms, which are important for both host 
physiological and defense functions. Microbiota metabolites such 
as SCFA (acetate, propionate, and butyrate) are important for 
metabolic functions in the gut but also have been shown to inter-
fere with immune responses, modulating inflammatory responses 
(11, 14, 28). Pneumonia induces disbiose and reduced levels of 
SCFA. SCFA are sensed by GPRs receptors, such as GPR43 and 
GPR109, leading to activation of signaling pathways in immune 
or epithelial cells (12, 13, 21).
GPR43 is the leading receptor for acetate and has been shown 
to control responses such as adipogenesis and modulation of gout 
inflammation (13, 29). Here, we highlighted the importance of 
the microbial metabolic sensor Gpr43 and its ligand acetate as 
modulators of lung innate immunity against bacterial pneumo-
nia. In the present study, we have shown for the first time that 
Gpr43 KO mice exhibit: (1) increased susceptibility to Kp lung 
infection, which was related to an (2) increased proliferation of 
bacteria in the airways of mice and uncontrolled inflammatory 
responses. The permanence of neutrophils in the lung resulted 
in greater lung damage following infection, with increased his-
tological score. In addition, (3) GPR43 expression in neutrophils 
and MF was important for the phagocytosis and for bacterial 
killing. Finally, we showed that the (4) acetate/GPR43 pathway 
is crucial during infection by promoting pathogen clearance and 
host recovery. SCFA mainly produced by gut commensal bacteria 
were shown to increase production of ROS in inflammatory cells 
contributing for an effective immune response, but importantly 
they have also been shown to play a role in the resolution of 
inflammation, by leading to apoptosis of neutrophils, produc-
tion of anti-inflammatory cytokines, and restoration of tissue 
homeostasis (11, 28).
It is known that during pneumonia, an unregulated inflamma-
tory response can lead to intense lung injury, loss of function, and 
poor prognosis. In this regard, we observed that GPR43 absence 
resulted in increased influx and persistence of neutrophils, which 
supports the increased levels of IL-1β. IL-1β production is an 
important cytokine mediating crucial immune responses against 
Kp (30); therefore, higher levels of this cytokine in Gpr43−/− 
mice could be contributing to the increased pulmonary tissue 
injury. Interestingly, despite the greater inflammatory response 
in GPR43-deficient animals, an increased number of bacteria 
was observed in the lung of those animals in comparison with 
wild-type mice. Therefore, instead of dealing with the pathogen, 
the increased inflammatory response contributed to the pathol-
ogy observed in the lungs. Aiming a better understanding over 
the uncontrolled proliferation of bacteria in the airways of 
Gpr43−/− mice, we showed that the functions of neutrophils and 
MF (phagocytosis of bacteria) were impaired as demonstrated by 
the in vitro data. Altogether, GPR43 plays a crucial role in both 
modulation of inflammation and control of pathogen burden. 
Indeed, we and others have shown that the signaling triggered by 
acetate-GPR43 in inflammatory cells leads to increased produc-
tion of ROS, activation of inflammasome, increased phagocyto-
sis, and killing of bacteria (13, 23). On the other hand, GPR43 
signaling is also important to balance inflammation leading to a 
FigUre 6 | In vitro neutrophils analyses of phagocytosis and cytokines production after Klebsiella pneumoniae (Kp) exposure. (a) Bone marrow neutrophils from 
wild type and Gpr43−/− were incubated with opsonized-pHRodo-marked Kp (MOI 1:1) and acetate (1 mM) for 120 min. Samples were analyzed by flow cytometer, 
and the mean fluorescence of bacteria within the cells were analyzed. (B) IL-10 and (c) IL-1β were measured in supernatant from neutrophils by ELISA. Results are 
presented as mean ± SEM (n=6). C− = without bacteria C+ = with bacteria. *Statistical difference (P < 0.05) when compared with WT control (ANOVA—Posttest 
Newman–Keuls). **Statistical difference (P < 0.01) when compared with WT control without bacteria (ANOVA—Posttest Sidak’s). Results are representative of three 
independent experiments.
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mild recruitment of neutrophils and production of pro-resolving 
mediators. In this regard, it culminates with an effective clearance 
of bacteria and reduction of the collateral lung injury. In agree-
ment with our results, the acetate/Gpr43 pathway was shown to 
promote resolution of inflammation in an experimental model of 
gout (28) and was also shown to be important to prime germ-free 
(GF) mice’s MF, improving their ability to respond to a sterile 
insult (13). Since long-lasting inflammatory responses can lead 
to severe lung injury, timely resolution of the inflammation is 
critical for the host to minimize tissue damage and to regain 
homeostasis (31).
Klebsiella pneumoniae, an opportunistic Gram-negative path-
ogen, triggers an important inflammatory response in the lungs 
mainly due to the recognition of membrane LPS. Here, we have 
showed that MF harvested from acetate-treated mice and exposed 
to LPS could induce higher chemotaxis of neutrophils from WT 
mice than of MF isolated from non-treated mice. Importantly, 
this phenomenon was dependent on GPR43 since neutrophils 
derived from GPR43-deficient mice did not migrate as much as 
the wild-type cells did. Therefore, it suggests that acetate priming 
of peritoneal MF is important to prompt an initial inflamma-
tory response and neutrophil recruitment into the lungs. These 
results reinforced the dual role of GPR43 in mediating the proper 
immune response against Kp. We hypothesize that, in early time 
points, acetate stimulates neutrophils recruitment and activation 
in vivo assuring the killing of bacteria, and on the other hand, 
later during the infection, acetate contributes to the resolution 
of pulmonary inflammation/injury probably by diminishing 
neutrophil survival by the increase of IL-10 production (22).
The concept of the host microbiota being pivotal to the matu-
rity and function of the immune system, especially assuring host 
defense against pathogens is well appreciated in the literature. GF 
mice display a significantly different inflammatory responsiveness 
pattern when compared to conventional mice, being hyporespon-
sive to infections (9, 26).
Notably, several works have described the role of gut micro-
biota to improve lung defenses by directly activating local cells 
thought PRR signaling by LPS or PSA components, for example 
(9, 10, 26). Despite this, gut microbiota disruptions due to 
dietary or to antibiotics treatment have also been associated to 
pulmonary diseases suggesting that microbiota composition 
plays an important role to lung immune responses (19, 32, 33). 
The intestinal microbiota exhibits dynamic responses to exter-
nal stimulation (i.e., diets). Poor quality diets or an unbalanced 
energy that can lead to malnutrition have been described to lead 
to changes in the gut microbiota composition (34, 35) that can 
influence disease progression and abnormalities of the leuko-
cytes, impairing the proper defense against infections (36, 37). 
Indeed, malnutrition has been known as the main contributor 
to deaths from infections, even after HIV burden (38). In this 
regard, malnutrition is one of the leading risk factors to the 
development of pneumonia. Moreover, malnourished patients 
are more likely to die from pneumonia than well-nourished 
ones (39). Recently, Desai and collaborators (40) have described 
that low fiber dietary was related to functional changes associ-
ated to intestinal dysbiosis and host susceptibility to intestinal 
infection. Furthermore, of equally importance, dietary fiber 
supplementation and SCFA, on the other hand, have been 
shown to protect mice not only by promoting host intestinal 
homeostasis but also against pulmonary inflammation in aller-
gic diseases (19, 21). These findings are particularly relevant to 
our own regarding to the fact that deficiency in the microbial 
metabolic sensor GPR43, which recognizes acetate produced by 
microbiota fermentation of fiber, increased susceptibility to Kp 
infection.
Herein, we hypothesize that Gpr43-dependent effect of SCFA 
during bacterial pulmonary infections leads to a controlled 
inflammatory response. This raises the idea that GPR43 may be a 
relevant receptor that interfaces the crosstalk between host health 
nutritional state and lung immunity by intestinal microbiota 
energy source.
Moreover, once intestinal microbiota, especially acting 
through production of active metabolites, dictates the host ability 
and resistance against pathogens, interfering with gut micro-
biota or given probiotics might provide new perspective and 
approaches to pulmonary infections. In this regard, a recent clini-
cal trial reported that probiotic therapy using the bacterial strain 
Lactobacillus plantarum prevented infections, respiratory ones 
included, in newborns (41). Also, our group has already shown in 
a murine experimental model of pneumonia that treatment with 
the commensal bacteria Bifidobacterium longum 51A protected 
mice from Kp lung infection (22). This effect was in part due to 
the modulation of AMs activity though induction of ROS and of 
increasing the bacterial killing. Of note, these effects were ampli-
fied by the use of live probiotics. B. longum strain is well known 
characterized to be the most important bacteria that produce 
acetate, reinforcing thus our hypothesis that acetate produced by 
commensal bacteria may modulate the lung immune response 
against respiratory infections.
In conclusion, we report a previously unappreciated role of 
GPR43 in promoting host timely inflammation resolution of 
Gram-negative bacteria-induced lung injury. In addition, our 
study demonstrates that acetate-binding GPR43 can be critical for 
recovery from Kp-induced lung injury by modulating neutrophils 
and MF activity. Interventions that improve SCFA levels by gut 
microbiota may promote resolution of inflammation.
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